| Literature DB >> 33344617 |
Xi Yang1, Xiao-Guang He2, Dong-Hui Jiang1, Chun Feng1, Rui Nie1.
Abstract
BACKGROUND: Carotid body tumor (CBT) is a chemoreceptor tumor located in the carotid body, accounting for approximately 0.22% of head and neck tumors. Surgery is the main treatment method for the disease. CASEEntities:
Keywords: Carotid body tumor; Case report; Continuous positive airway pressure; Head and neck; Hypoxemia; Obstructive sleep apnea-hypopnea syndrome
Year: 2020 PMID: 33344617 PMCID: PMC7723711 DOI: 10.12998/wjcc.v8.i23.6150
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1Magnetic resonance imaging showing bilateral carotid body tumors.
Clinical features of the patient
|
|
|
|
| Height, 168 cm; body weight, 86 kg; BMI, 30.4; blood pressure, 160/100 mmHg. No significant change in body weight occurred before and after the surgery |
|
|
| Snoring; apnea; labored breathing; occasional arousal; mental fatigue during the daytime; frequent hypersomnia; inability to work |
|
|
| Cyanotic lips; conjunctival congestion; mouth deviation to the left; and shallow nasolabial fold. The extended tongue was left-deflected. The tonsil was enlarged (grade I), and the body and base of the tongue and soft palate showed hypertrophy. The Friedman stage was type III. The muscle strength of the four limbs was normal. No dyspnea and three concave signs were noted. The Epworth hypersomnia scale (ESS) scored 21 points. The breath sounds of both lungs were clear, and the heart rhythm was regular. No pathological murmurs were heard |
|
|
| No family history of CBT; No alcohol or tobacco; No previous history of hypertension or lung and cerebrovascular diseases. Previously, he had snoring and mouth breathing at night, but no apnea and arousal caused by labored breathing. He had a 10-yr history of anxiety, mania, and insomnia aggravated after CBT surgery |
|
|
| Risperidone tablets (4 mg qd); sodium valproate (0.2 g bid); quetiapine (50 mg qd); and nifedipine sustained-release tablets (20 mg bid) |
BMI: Body mass index; CBT: Carotid body tumor.
Polysomnography results
|
| |
|
| |
| T1 | 46.2% |
| T2 | 31.2% |
| T3 | 3.2% |
| REM | 19.4% |
|
| |
| AHI | 22.3 times/h |
| Obstructive sleep apnea | 106 times; Maximum duration, 192 s |
| Sleep microarousal index | 25.3 times/h |
|
| |
| Lowest awake SpO2 | 76% |
| Lowest sleep SpO2 | 36% |
| Total time of SpO2 below 90%/TST | 30.4% |
TST: Total sleep time; REM: Rapid eye movement; AHI: Apnea–hypopnea index; SpO2: Saturation of pulse oximetry.
Figure 2Manual pressure titration and pressure profile of the whole night manual pressure titration. A: Manual pressure titration before oxygen therapy: During the whole-night pressure titration, at 1:43 am, the patient had no respiratory events or snoring, but saturation of pulse oximetry (SpO2) fluctuated between 85% and 88%; B: Manual pressure titration after oxygen therapy: Oxygen therapy at 1 L/min was given at 4:28 am. He reported no respiratory events or snoring during rapid eye movement sleep, and SpO2 fluctuated between 89% and 92%; C: Pressure profile of the whole night manual pressure titration: The whole-night pressure titration was 90% expiratory positive airway pressure 7.5 cmH2O and 90% inspiratory positive airway pressure 11 cmH2O. Pressure titration achieved good effects. IPAP: Inspiratory positive airway pressure; EPAP: expiratory positive airway pressure.
Figure 3Flow chart illustrating the physiopathologic mechanism of the secondary aggravation of obstructive sleep apnea–hypopnea syndrome and hypoxemia. CBT: Carotid body tumor; OSAHS: Obstructive sleep apnea–hypopnea syndrome; Po2: Oxygen pressure; Pco2: Carbon dioxide pressure; HCO3: Bicarbonate.